who invented glp 1 Lotte Bjerre Knudsen: The Scientist Drove GLP-1 Drugs For Obesity and Alzheimer's GLP-1-based therapy for obesity -

Furthermore, the interaction of ACTL6A with GCLC promoter was weakened by NRF2 KD, and likewise, the interaction of NRF2 with GCLC promoter was weakened by ACTL6A KD (Fig

Inhibition of SGLT-1 in the small intestine causes more glucose transport to the distal intestine and colon, resulting in greater fermentation of glucose to SCFAs by luminal bacteria and increased sustained release of GLP-1 in the distal intestine [174] (Fig

Many stack the two for greater results

In terms of physical effects, some might notice an increase in their metabolic rate, which, when combined with a healthy lifestyle, leads to more efficient fat burning and gradual weight loss